I don't think Crispr has much impact on RNAi, at least not in foreseeable future as it is entirely different approach. I agree with genisi on the hurdle ahead of Crispr for clinical impact. Think where RNAi was 10 years ago, it would take at least that long if not longer for Crisp to have similar impact RNAi has today IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.